A study to assess the occurrence of metabolic diseases associated with the use of antipsychotic drugs in Korean schizophrenia patients based on the national health insurance database

Kyung Hee University Hospital0 个研究点目标入组 10,000 人开始时间: 待定最近更新: 2019年3月25日

试验速览

暂无简介。

•1)Patients who were registered in the National Health Insurance database, and whose data (from the time of diagnosis to 2015) can be used for the analysis.
•2)Patients who were diagnosed as schizophrenia in 2008-2010 (patients with the F20 code of International Classification of Diseases, 10th Revision (ICD-10)).

•1) Patients who can not be included in the analysis due to missing information of demographics (date of birth, gender, age, etc.) diseases (i.e., name of disease), or prescription (i.e., name of prescribed drug)
•2) In the case of patients who were treated with clozapine, the data cannot be included in the analysis when the information required for the analysis (e.g., drug information, average daily dose, total number of days of administration, and so on) is missing.

发起方

Kyung Hee University Hospital